Patents by Inventor Rob Burke

Rob Burke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid-polypeptide compositions and uses thereof
    Patent number: 12234290
    Abstract: Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a polynucleic acid molecule and a polymer. Also described herein include methods for treating a cancer which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: February 25, 2025
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Andrew John Geall, Venkata Ramana Doppalapudi, David Sai-Ho Chu, Michael Caramian Cochran, Rachel Elizabeth Johns, Palani Balu, Rob Burke, Beatrice Diana Darimont
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20240400707
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
    Type: Application
    Filed: August 19, 2024
    Publication date: December 5, 2024
    Inventors: Barbora MALECOVA, Rob BURKE, Beatrice Diana DARIMONT, David SALA CANO
  • Compositions and methods of treating facioscapulohumeral muscular dystrophy
    Patent number: 12157774
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
    Type: Grant
    Filed: January 2, 2024
    Date of Patent: December 3, 2024
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Barbora Malecova, Rob Burke, Beatrice Diana Darimont, David Sala Cano
  • NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON SKIPPING
    Publication number: 20240358736
    Abstract: Disclosed herein are molecules and pharmaceutical compositions that induce an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion. Also described herein include methods for treating a disease or disorder that comprises a molecule or a pharmaceutical composition that induces an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion.
    Type: Application
    Filed: July 11, 2024
    Publication date: October 31, 2024
    Inventors: Arthur A. LEVIN, Andrew John GEALL, Venkata Ramana DOPPALAPUDI, Michael Caramian COCHRAN, Hanhua HUANG, Rob BURKE
  • Compositions and methods of treating facioscapulohumeral muscular dystrophy
    Patent number: 12104156
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
    Type: Grant
    Filed: November 4, 2022
    Date of Patent: October 1, 2024
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Barbora Malecova, Rob Burke, David Sala Cano, Beatrice Diana Darimont
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20240309382
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
    Type: Application
    Filed: May 9, 2024
    Publication date: September 19, 2024
    Inventors: Barbora MALECOVA, Rob BURKE, David SALA CANO, Beatrice Diana DARIMONT
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20240287522
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
    Type: Application
    Filed: April 16, 2024
    Publication date: August 29, 2024
    Inventors: Barbora MALECOVA, Rob BURKE, David SALA CANO, Beatrice Diana DARIMONT
  • Compositions and methods of treating facioscapulohumeral muscular dystrophy
    Patent number: 12071485
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
    Type: Grant
    Filed: January 2, 2024
    Date of Patent: August 27, 2024
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Barbora Malecova, Rob Burke, Beatrice Diana Darimont, David Sala Cano
  • Nucleic acid-polypeptide compositions and methods of inducing exon skipping
    Patent number: 12064483
    Abstract: Disclosed herein are molecules and pharmaceutical compositions that induce an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion. Also described herein include methods for treating a disease or disorder that comprises a molecule or a pharmaceutical composition that induces an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion.
    Type: Grant
    Filed: June 17, 2022
    Date of Patent: August 20, 2024
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Arthur A. Levin, Andrew John Geall, Venkata Ramana Doppalapudi, Michael Caramian Cochran, Hanhua Huang, Rob Burke
  • Compositions and methods of treating Facioscapulohumeral muscular dystrophy
    Patent number: 12049629
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
    Type: Grant
    Filed: November 4, 2022
    Date of Patent: July 30, 2024
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Barbora Malecova, Rob Burke, David Sala Cano, Beatrice Diana Darimont
  • Compositions and methods of treating facioscapulohumeral muscular dystrophy
    Patent number: 11999955
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
    Type: Grant
    Filed: November 4, 2022
    Date of Patent: June 4, 2024
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Barbora Malecova, Rob Burke, David Sala Cano, Beatrice Diana Darimont
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20240132610
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
    Type: Application
    Filed: January 2, 2024
    Publication date: April 25, 2024
    Inventors: Barbora MALECOVA, Rob BURKE, Beatrice Diana DARIMONT, David SALA CANO
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20240124600
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
    Type: Application
    Filed: January 2, 2024
    Publication date: April 18, 2024
    Inventors: Barbora MALECOVA, Rob BURKE, Beatrice Diana DARIMONT, David SALA CANO
  • Compositions and methods of treating facioscapulohumeral muscular dystrophy
    Patent number: 11912779
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
    Type: Grant
    Filed: September 15, 2022
    Date of Patent: February 27, 2024
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Barbora Malecova, Rob Burke, Beatrice Diana Darimont, David Sala Cano
  • Compositions and methods of treating muscle atrophy and myotonic dystrophy
    Patent number: 11872287
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
    Type: Grant
    Filed: September 27, 2022
    Date of Patent: January 16, 2024
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Andrew John Geall, Venkata Doppalapudi, David Sai-Ho Chu, Michael Caramian Cochran, Michael Hood, Beatrice Diana Darimont, Rob Burke, Yunyu Shi, Gulin Erdogan Marelius, Barbora Malecova
  • COMPOSITIONS AND METHODS OF TREATING MUSCLE DYSTROPHY
    Publication number: 20230398231
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle dystrophy (DM1).
    Type: Application
    Filed: May 31, 2023
    Publication date: December 14, 2023
    Inventors: Venkata Ramana DOPPALAPUDI, Michael David HOOD, Rob BURKE, Michael Caramian COCHRAN, Beatrice Diana DARIMONT, Yunyu SHI, Gulin Erdogan MARELIUS, Barbora MALECOVA
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20230340474
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
    Type: Application
    Filed: November 4, 2022
    Publication date: October 26, 2023
    Inventors: Barbora MALECOVA, Rob BURKE, David SALA CANO, Beatrice Diana DARIMONT
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20230287420
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
    Type: Application
    Filed: November 4, 2022
    Publication date: September 14, 2023
    Inventors: Barbora MALECOVA, Rob BURKE, David SALA CANO, Beatrice Diana DARIMONT
  • COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20230279395
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
    Type: Application
    Filed: November 4, 2022
    Publication date: September 7, 2023
    Inventors: Barbora MALECOVA, Rob BURKE, David SALA CANO, Beatrice Diana DARIMONT
  • Compositions and methods of treating muscle atrophy and myotonic dystrophy
    Patent number: 11712478
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
    Type: Grant
    Filed: October 12, 2021
    Date of Patent: August 1, 2023
    Assignee: AVIDITY BIOSCIENCES, INC.
    Inventors: Andrew John Geall, Venkata Ramana Doppalapudi, David Sai-Ho Chu, Michael Caramian Cochran, Michael Hood, Beatrice Diana Darimont, Rob Burke, Yunyu Shi, Gulin Erdogan Marelius, Barbora Malecova